Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Biological markers for identifying patients for treatment with VEGF antagonists

Biological markers for identifying patients for treatment with VEGF antagonists

US Patent 10364466 · Granted Jul 30, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of treating cancer with an mTOR inhibitor2024
B7-H4 antibodies and methods of use thereof2023
Ras inhibitors2023
SHP2 inhibitor compositions and methods for treating cancer2023
B7-H4 antibodies and methods of use thereof2022
Combination therapy for the treatment of glioblastoma2020
Diagnostic methods and compositions for treatment of glioblastoma2019
Method of treatment for glioblastoma by administering a VEGF antagonist2019
Anti-neuropilin antibodies and methods of use2015
Compositions and methods for modulating vascular development2014
Combinations of phosphoinositide 3-kinase inhibitor compounds chemotherapeutic a2013
Antibodies to EGFL7 and methods for their use2013